James W. Mccollum - May 13, 2024 Form 4 Insider Report for LENZ Therapeutics, Inc. (LENZ)

Role
Director
Signature
/s/ Evert Schimmelpennink, as Attorney-in-Fact
Stock symbol
LENZ
Transactions as of
May 13, 2024
Transactions value $
$501,093
Form type
4
Date filed
5/14/2024, 05:29 PM
Previous filing
Mar 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LENZ Common Stock Purchase $501K +31.3K +6.34% $15.99* 526K May 13, 2024 By trust F1
holding LENZ Common Stock 95K May 13, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 31,332 shares purchased in the price range of $15.96 to $16.00 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.